Literature DB >> 22313459

TPA induces the expression of EC-SOD in human monocytic THP-1 cells: involvement of PKC, MEK/ERK and NOX-derived ROS.

Junya Makino1, Tetsuro Kamiya, Hirokazu Hara, Tetsuo Adachi.   

Abstract

Extracellular-superoxide dismutase (EC-SOD) is a major SOD isozyme mainly present in the vascular wall. EC-SOD is also observed in monocytes/macrophages, and its high expression contributes to the suppression of atherosclerosis by scavenging superoxide. The molecular mechanisms governing cell-specific expression of EC-SOD are mostly unknown, while the anti-oxidative effect of EC-SOD is well recognized. In this study, we investigated the expression of EC-SOD during 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced monocytic differentiation of THP-1 cells, which is not expressing its gene in the basal phase. We confirmed the significant induction of EC-SOD in a TPA time-dependent manner, and that induction was completely blocked by pre-treatment with GF109203X, an inhibitor of protein kinase C, U0126 and PD98059, inhibitors of mitogen-activated protein kinase kinase/extracellular-signal regulated kinase. Moreover, we determined the involvement of NADPH oxidase-derived reactive oxygen species in that induction. Overall, we considered that these results may contribute to clarify the cell-specific expression of EC-SOD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22313459     DOI: 10.3109/10715762.2012.664841

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  9 in total

1.  Stable Expression and Characterization of an Optimized Mannose Receptor.

Authors:  David J Vigerust; Sherell Vick; Virginia L Shepherd
Journal:  J Clin Cell Immunol       Date:  2015-06-06

2.  Effects of selenoprotein S on oxidative injury in human endothelial cells.

Authors:  Yin Zhao; Hua Li; Li-li Men; Rong-chong Huang; Hai-cheng Zhou; Qian Xing; Jun-jie Yao; Chun-hong Shi; Jian-ling Du
Journal:  J Transl Med       Date:  2013-11-14       Impact factor: 5.531

Review 3.  The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases.

Authors:  Hor-Yue Tan; Ning Wang; Sha Li; Ming Hong; Xuanbin Wang; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2016-04-06       Impact factor: 6.543

4.  Caffeic acid phenethyl ester suppresses monocyte adhesion to the endothelium by inhibiting NF-κB/NOX2-derived ROS signaling.

Authors:  Risa Nakahara; Junya Makino; Tetsuro Kamiya; Hirokazu Hara; Tetsuo Adachi
Journal:  J Clin Biochem Nutr       Date:  2016-04-13       Impact factor: 3.114

5.  Cross Talk Mechanism among EMT, ROS, and Histone Acetylation in Phorbol Ester-Treated Human Breast Cancer MCF-7 Cells.

Authors:  Tetsuro Kamiya; Aki Goto; Eri Kurokawa; Hirokazu Hara; Tetsuo Adachi
Journal:  Oxid Med Cell Longev       Date:  2016-03-31       Impact factor: 6.543

6.  Clinical relevance of thyroid cell models in redox research.

Authors:  Francesca Cammarota; Francesco Fiscardi; Tiziana Esposito; Gabriella de Vita; Marco Salvatore; Mikko O Laukkanen
Journal:  Cancer Cell Int       Date:  2015-12-09       Impact factor: 5.722

7.  TLR2 activation induces antioxidant defence in human monocyte-macrophage cell line models.

Authors:  Iwona Karwaciak; Michal Gorzkiewicz; Grzegorz Bartosz; Lukasz Pulaski
Journal:  Oncotarget       Date:  2017-04-21

8.  Liquiritin suppresses UVB‑induced skin injury through prevention of inflammation, oxidative stress and apoptosis through the TLR4/MyD88/NF‑κB and MAPK/caspase signaling pathways.

Authors:  Xiao-Qing Li; Li-Min Cai; Jing Liu; Yan-Li Ma; Ying-Hui Kong; He Li; Ming Jiang
Journal:  Int J Mol Med       Date:  2018-06-05       Impact factor: 4.101

9.  Inhibitory mechanism of ginsenoside Rh3 on granulocyte-macrophage colony-stimulating factor expression in UV-B-irradiated murine SP-1 keratinocytes.

Authors:  Young Sun Park; Ji Eun Lee; Jong Il Park; Cheol Hwan Myung; Young-Ho Lim; Chae Kyu Park; Jae Sung Hwang
Journal:  J Ginseng Res       Date:  2018-12-24       Impact factor: 6.060

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.